OTCMKTS:RYMDF Relay Medical (RYMDF) Stock Price, News & Analysis $0.0086 0.00 (0.00%) As of 06/25/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Relay Medical Stock (OTCMKTS:RYMDF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Relay Medical alerts:Sign Up Key Stats Today's Range$0.0086▼$0.008650-Day Range$0.01▼$0.0252-Week Range$0.13▼$0.72VolumeN/AAverage Volume68,743 shsMarket Capitalization$2.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewRelay Medical Corp. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. Its platform technologies include HemoPalm and Pharmatrac. The HemoPalm develops a POCT unit-use cartridge based blood analyzer with full enterprise capabilities. The Pharmatrac is an AI and data analytics driven personal medication management system that addresses the growing problem of non-adherence to treatment. The company was founded by James Samsoondar in 2005 and is headquartered in Toronto, Canada.Read More… Receive RYMDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Relay Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address RYMDF Stock News HeadlinesCNN’s Top Doc Relays Medical Community’s ‘Horror’ Over RFK Jr.November 15, 2024 | msn.comRelay Therapeutics' combo therapy for breast cancer cuts disease progression in early studySeptember 9, 2024 | reuters.comThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains. | Weiss Ratings (Ad)Relay Therapeutics Shares Jump on Positive Results for Breast Cancer TreatmentSeptember 9, 2024 | marketwatch.comRelay stock rallies 41% on positive data for RLY-2608September 9, 2024 | msn.comJoin Relay and 9to5Mac in supporting St. Jude Children’s Research HospitalAugust 28, 2024 | 9to5mac.com9'Relay FM' Podcast Network Launches Annual Fundraiser for St. Jude Children's Research HospitalAugust 28, 2024 | macrumors.comMAmericans run blazing time in 4×100-meter relay — and could still get benched for Olympic finalsAugust 10, 2024 | nypost.comNSee More Headlines RYMDF Stock Analysis - Frequently Asked Questions How have RYMDF shares performed this year? Relay Medical's stock was trading at $0.0102 at the beginning of 2025. Since then, RYMDF shares have decreased by 15.7% and is now trading at $0.0086. View the best growth stocks for 2025 here. How do I buy shares of Relay Medical? Shares of RYMDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today6/28/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:RYMDF CIKN/A Webwww.relaymedical.com Phone(647) 872-9982FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares241,197,000Free FloatN/AMarket Cap$2.06 million OptionableNot Optionable Beta1.15 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTCMKTS:RYMDF) was last updated on 6/28/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"Everything just changed. Senate passes the GENIUS Act 68-30. First major crypto bill in history. You have 4...Crypto 101 Media | SponsoredGold Just Jumped Again. Here’s How to Get PaidGold prices just spiked again. As I write this, gold is trading near $3,400 an ounce. But here's the thi...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Shocking Link Between A.I. and Your MoneyThe AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump Knows Exactly What He’s Doing…With Trump in office, new money is flowing in and out of the market like never before... And some folks usi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
